Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, Mar 2026 and Jul 2026.
- Largest single sale: $1.3M (2,633 shares) of Vertex Pharmaceuticals on Mar 11, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP, Chief Commercial Officer | Jul 2, 2025 | Jul 7, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 2, 2026, Vertex Pharmaceuticals: sold 1,541 shares for $800K, under a disclosed plan. 1 filing: 1
- Mar 11, 2026, Vertex Pharmaceuticals: sold 2,633 shares for $1.3M, under a disclosed plan. 1 filing: 1
- Mar 4, 2026, Vertex Pharmaceuticals: sold 2,437 shares for $1.2M, under a disclosed plan. 1 filing: 1
- Feb 25, 2026, Vertex Pharmaceuticals: sold 4,910 shares for $2.4M, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 873 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.